![Lurasidone Piperazine N-Oxide ;(1S,2R,6S,7R)-4-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)-1-oxidopiperazin-1-ium-1-yl]methyl]cyclohexyl]methyl]-4-azatricyclo[5.2.1.02,6]decane-3,5-dione; 4-(Benzo[d]isothiazol-3-yl)-1-(((1R,2R)-2-(((3aR,4S,7R,7aS)-1,3-dioxohexahydro-1H-4,7-methanoisoindol-2(3H)-yl)methyl)cyclohexyl)methyl)piperazine 1-oxide |574569-32-6](https://drjcrbio.com/wp-content/uploads/1574569-32-6.png)
Lurasidone Piperazine N-Oxide ;(1S,2R,6S,7R)-4-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)-1-oxidopiperazin-1-ium-1-yl]methyl]cyclohexyl]methyl]-4-azatricyclo[5.2.1.02,6]decane-3,5-dione; 4-(Benzo[d]isothiazol-3-yl)-1-(((1R,2R)-2-(((3aR,4S,7R,7aS)-1,3-dioxohexahydro-1H-4,7-methanoisoindol-2(3H)-yl)methyl)cyclohexyl)methyl)piperazine 1-oxide |574569-32-6
Lurasidone, Lurasidone Piperazine N-Oxide
Description
| Code: JCLRS-10 |
| CAS: 1574569-32-6 |
| Chemical Formula:C28H36N4O3S |
| Molecular Weight:508.68 |
| Category: Reference Standards/API Drug Metabolites/EP Impurities/USP Impurities |
| Literature: |
| Application: Lurasidone Piperazine N-Oxide ;(1S,2R,6S,7R)-4-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)-1-oxidopiperazin-1-ium-1-yl]methyl]cyclohexyl]methyl]-4-azatricyclo[5.2.1.02,6]decane-3,5-dione; 4-(Benzo[d]isothiazol-3-yl)-1-(((1R,2R)-2-(((3aR,4S,7R,7aS)-1,3-dioxohexahydro-1H-4,7-methanoisoindol-2(3H)-yl)methyl)cyclohexyl)methyl)piperazine 1-oxide |574569-32-6is useful as reference Impurity standard. |
